Description
This ERN RARE-LIVER joint Webinar was held on 15 July 2025 with UMCG-Groningen, UKE-Hamburg and Amsterdam University Medical Centre.
CM is characterised by the abnormal dilatation of the bile duct, which can occur in the extrahepatic bile duct, intrahepatic bile ducts, or both. The bile duct of these patients is affected before birth. Some malformations are not uniformly dilatated but are more irregular, a condition termed the fusiform variant (7). CM occurs with a higher prevalence in Asian populations than in Western populations, where the incidence is estimated to be 1:100,000 to 1:150,000 live births. Recent advancements in diagnostic imaging during antenatal screening with ultrasound have increased the detection rates of CMs.The Todani classification system categories CMs into five types based on anatomical imaging or operative findings, each with its own treatment algorithm. Historically, the management of CMs involved drainage procedures, such as cystoduodenostomy or cystojejunostomy. These procedures have largely been abandoned due to their inability to resolve the underlying problem, the persistence of recurrent infections, and the risk of malignant transformation of the in situ malformation. The recognition of CM as a premalignant condition has led to a shift towards complete or near-complete cyst excision, making it the standard therapy for patients that are fit for surgery. The resection is followed by a biliodigestive reconstruction, typically via Roux-en-Y hepaticojejunostomy.
For the genuinely a-symptomatic child with CM, determining the optimal timing of surgery is challenging due to the unknown risk of complications arising. For the adult with advanced age balancing the risk between CCA and perioperative risks is challenging. We address the evidence available for the European setting.
- Diagnosis and classification of CM
- Risk of CCA in CM
- Resection vs follow up
- Timing of therapy
- Type of biliary reconstruction
- Complications of resection and complication of wait